Proposal to increase pack sizes for general sale of ranitidine rejected

Pharmacist intervention for the drug is “critical”, says delegate, while further interim decisions were made to downschedule rizatriptan, modified release melatonin and topical adapalene An interim decision has been made to reject a proposal to increase the pack sizes available for general sale and in pharmacies for ranitidine, based on ACMS advice that the current

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Barriers and enablers to safe medication management
Next 1969: the right kind of pharmacy